Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review Keith C. FerdinandKeith C. NorrisJennifer M. Trujillo Review Open access 26 September 2023 Pages: 1979 - 1996
Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First-in-Class Twincretin Richard J. MacIsaacGary DeedRoy Rasalam Review Open access 12 October 2023 Pages: 1997 - 2014
The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review Soodeh JahangiriMojtaba MalekMohammad E. Khamseh Review Open access 14 October 2023 Pages: 2015 - 2030
Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England Adrian H. HealdDavid A. Jenkinson behalf of the CVD-COVID-UK/COVID-IMPACT Consortium Original Research Open access 25 August 2023 Pages: 2031 - 2042
Correction to: Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England Adrian H. HealdDavid A. Jenkinson behalf of the CVD-COVID-UK/COVID-IMPACT Consortium Correction Open access 05 October 2023 Pages: 2043 - 2044
Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States Reema R. ModyKellie L. MeyerKen B. O’Day Original Research Open access 28 September 2023 Pages: 2045 - 2055
Addressing Insulin Injection Technique: A Follow-up Study of Canadian Patients with Diabetes Basel BariMarie-Andrée CorbeilArthur Vasquez Original Research Open access 30 September 2023 Pages: 2057 - 2074
LIVE INDIA: Effectiveness of Gla-100 in a Post hoc Pooled Analysis of FINE ASIA and GOAL Registries Vaishali DeshmukhTirthankar ChaudhuryGhanshyam Goyal Original Research Open access 04 October 2023 Pages: 2075 - 2088
Effect of Neo-Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD Giuseppina GuarinoFelice StrolloSandro Gentile Original Research Open access 04 October 2023 Pages: 2089 - 2108
Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus Jennifer Ken-OpurumSistla S. S. SrinivasRonald Preblick Original Research Open access 06 October 2023 Pages: 2109 - 2125
Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy Vincenzo M. MondaClaudio VociSandro Gentile Original Research Open access 06 October 2023 Pages: 2127 - 2142
A Simplified Screening Model to Predict the Risk of Gestational Diabetes Mellitus in Pregnant Chinese Women Yanbei DuoShuoning SongWeigang Zhao Original Research Open access 16 October 2023 Pages: 2143 - 2157
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care Mario Luca MorieriRiccardo Candidofor the PIONEERING EXPERIENCE study group Original Research Open access 18 October 2023 Pages: 2159 - 2172
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial Hitoshi IshiiTomonori OuraMasakazu Takeuchi Brief Report Open access 16 October 2023 Pages: 2173 - 2183